// App-Quantinova.ai

: Impact of Cytomegalovirus (CMV) Sero-Conversion Pre Allogeneic Stem Cell Transplant on Post-Transplant Outcomes

Researchers

Presenter

  • Ayman Sayyed

Principal Investigators

  • Leeann Wilson

  • Vered Stavi

  • Shiyi Chen

  • Jonas Mattsson

  • Jeffrey H. Lipton

  • Dennis D.H. Kim

  • Auro Viswabandya

  • Rajat Kumar

  • Wilson Lam

  • Arjun D. Law

  • Armin Gerbitz

  • Ivan Pasic

  • Igor Novitzky-Basso

  • Fotios V. Michelis

Medical Centers

  • Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada

  • Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Oncology (ONC)

Disease

  • Cytomegalovirus infection

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Letermovir

  • Allopurinol

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved